PSMA PET Imaging of Recurrent Prostate Cancer

Inclusion Criteria:

- Biopsy proven adenocarcinoma of the prostate

- Initially treated with definitive local therapy (surgery and radiation therapy are the
most common treatments, but other treatments are also eligible)

- For patients initially treated with surgery, radiation therapy, brachytherapy, or
cryotherapy:

° PSA ≥ 0.2 ng/mL in at least two consecutive tests within 6 months of date of consent
for patients

- For patients who have received additional treatment in the recurrent or metastatic
setting:

° PSA ≥ 2 ng/ml above the most recent therapy nadir

- Age ≥ 18 years

- Patient must be able to tolerate PET/CT or PET/MR imaging

Exclusion Criteria:

- Patient with claustrophobia that would preclude PET/CT or PET/MR imaging or other
contraindications to CT imaging.